申请人:Bayer Aktiengesellschaft
公开号:US05594010A1
公开(公告)日:1997-01-14
The substituted monopyridyl and bipyridyl derivatives are prepared by reacting substituted pyridine halides with phenylboronic acids. They are suitable for use as active compounds in medicaments for treating arterial hypertension and atherosclerosis.
被替代的单吡啶和双吡啶衍生物是通过将取代的吡啶卤化物与苯基硼酸反应制备而成。它们适用于作为治疗动脉高血压和动脉粥样硬化的药物中的活性化合物。